Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine vs Lidocaine for Postoperative Pain in Thyroid Surgery
NCT04427904Phase 2Recruiting
- Sponsor
- St. Joseph's Healthcare Hamilton
- Start
- Jun 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by St. Joseph's Healthcare Hamilton. Primary endpoint: Postoperative Pain at 12 hours. Started Jun 2022; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04427904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04427904.